Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Midostaurin in Elderly FLT3+ AML
NCT01846624Phase 2Terminated
- Start
- Jun 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midostaurin in acute myeloid leukemia (AML). Started Jun 2013; status: terminated.
02
Drugs
midostaurin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01846624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01846624.